The Analyst,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 30, 2024
The
alterations
in
blood
serum
optical
signal
caused
by
a
freeze–thaw
cycle
do
not
affect
patient
classification
or
disease
diagnosis.
may
be
performed
prior
to
spectroscopy
analysis
clinical
diagnostics.
Journal of Biophotonics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 6, 2025
ABSTRACT
The
aim
of
the
study
is
to
compare
performance
surface‐enhanced
Raman
spectroscopy
(SERS)
analysis
serum
using
a
non‐cooled
detector
(
EnSpectr
R785
)
and
high
spectral
resolution
Renishaw
in
task
discrimination
between
patients
with
chronic
heart
failure
obstructive
pulmonary
disease.
SERS‐based
solution
classification
problem
demonstrates
an
insignificant
relationship
disease
accuracy
quality
(classification
for
high‐resolution
setup
0.84
low‐cost
0.81).
In
data
recorded
on
setup,
most
significant
bands
are
611,
675,
720,
804,
1187,
1495,
1847
cm
−1
;
setup—721,
1051,
1665
.
results
have
revealed
equal
capabilities
setups;
however,
has
more
prospects
identifying
contribution
pathologically
associated
analytes.
In
their
recent
publication,
Dong
et
al.
1
demonstrated
high
performance
of
SERS-based
liquid
biopsy
human
serum
analysis
for
earlier
cancer
detection.Moreover,
this
study
was
highlighted
in
News
&
Vies
section
Light
Science
and
Applications
journal
by
Shi
2
.No
doubt,
different
optical
techniques
nowadays
are
widely
used
the
biofluids
3-10
demonstrate
accuracy
possible
clinical
applications.At
same
time,
paper
may
be
treated
incorrectly
due
to
drawbacks
spectral
data
analysis.First
all,
proposed
evaluate
provided
classification
models
based
on
separation
acquired
into
training
test
sets.This
is
an
adequate
approach
machine
learning
prove
stability
11
.In
it
required
model
both
set
(comparability
proves
stability).Dong
divided
4:1
ratio
(training:test),
but
surprisingly
only
one
value
characterize
models.Actually
mixed
from
groups
such
value.It
clearly
seen
data,
presented
figures
text,
that
demonstrates
whole
dataset
instead
two
values
test.As
example
collected
spectra
244
lung
(LC)
patients
324
healthy
controls
(HC).
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
Despite
the
prevalence
of
multiple
sclerosis,
there
is
currently
no
biomarker
by
which
this
disease
can
be
reliably
identified.
Existing
diagnostic
methods
are
either
expensive
or
have
low
specificity.
Therefore,
search
for
a
method
with
high
specificity
and
sensitivity,
at
same
time
not
requiring
complex
sample
processing
equipment,
urgent.
The
article
discusses
use
blood
serum
surface
enhanced
Raman
spectroscopy
in
combination
machine
learning
analysis
to
separate
persons
sclerosis
healthy
individuals.
As
spectra
projection
on
latent
structures-discriminant
was
used.
Using
above
methods,
we
obtained
possibility
ones
an
average
0.96
sensitivity
0.89.
main
bands
discrimination
against
individuals
632,
721-735,
1,048-1,076
cm-1.
In
general,
study
spectral
properties
using
promising
diagnosing
however,
further
detailed
studies
area
required.
Diagnostics,
Journal Year:
2025,
Volume and Issue:
15(6), P. 660 - 660
Published: March 8, 2025
Background/Objectives:
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
significant
public
health
concern,
affecting
millions
of
people
worldwide.
This
study
aims
to
use
Surface-Enhanced
Raman
Scattering
(SERS)
technology
detect
the
presence
respiratory
conditions,
with
focus
on
COPD.
Methods:
The
samples
human
serum
from
41
patients
diseases
(11
COPD,
20
bronchial
asthma
(BA),
and
10
asthma–COPD
overlap
syndrome)
103
ischemic
heart
disease,
complicated
by
chronic
failure
(CHF),
were
analyzed
using
SERS.
A
multivariate
analysis
SERS
characteristics
was
performed
Partial
Least
Squares
Discriminant
Analysis
(PLS-DA)
classify
following
groups:
(1)
all
versus
pathological
referent
group,
which
included
CHF
patients,
(2)
COPD
those
BA.
Results:
We
found
that
combination
at
638
1051
cm−1
could
help
identify
diseases.
PLS-DA
model
achieved
mean
predictive
accuracy
0.92
for
classifying
group
(0.85
sensitivity,
0.97
specificity).
However,
in
case
differentiating
between
BA,
only
0.61.
Conclusions:
Therefore,
metabolic
proteomic
composition
shows
differences
compared
but
BA
are
less
significant,
suggesting
similarity
general
pathogenetic
mechanisms
these
two
conditions.
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
significant
public
health
disease,
affecting
millions
of
subjects
globally.
This
study
proposes
Surface-Enhanced
Raman
Scattering
(SERS)
technique
to
determine
the
presence
respiratory
diseases
and
particularly
COPD.
The
samples
human
serum
41
patients
with
diseases,
103
chronic
heart
(CHD),
25
healthy
control
were
analyzed
by
means
SERS.
Multivariate
analysis
SERS
characteristics
was
performed
Partial
Least
Squares
Discriminant
Analysis
(PLS-DA)
classify
(1)
all
versus
group
including
CHD
(2)
COPD
bronchial
asthma
(BA).
We
found
that
combination
at
638
1051
cm−1
can
help
identifying
diseases.
PLS-DA
model
achieved
mean
predictive
accuracy
0.92
for
classifying
comparable
controls
(0.88
sensitivity,
0.96
specificity).
However,
in
cases
differentiation
BA
only
0.61.
Therefore,
metabolic
proteomic
composition
has
differences
compared
cases,
but
between
are
less
significant,
indicating
similarity
general
pathogenetic
mechanisms
these
two
conditions.